Skip to main content

Publications

6 publications

Funding

3 grants

Active

3 grants
  • Co-I
    Bridging Gaps and Transforming CARE for Young Breast Cancer Survivors and those with Metastatic Disease
    Centers for Disease Control and Prevention · 2024–2029
    No publications yet
    NU58DP007916-01-00
  • Co-I
    Dietary and Pharmacologic Interventions to Optimize Weight in Individuals with Breast Cancer
    Breast Cancer Research Foundation · 2026–2028
    BCRF-26-154
  • Co-I
    Correlative biomarkers to optimize breast cancer treatment and prevention strategies
    Breast Cancer Research Foundation · 2024–2026
    BCRF-24-154

Clinical research

2 studies

Active

1 study
  • PI
    ShortStop-HER2: Shortened Duration of Adjuvant Therapy in Patients With Early-Stage HER2+ Breast Cancer Who Achieve pCR After Neoadjuvant Chemotherapy With HER2 Blockade
    PHASE3 · Alliance for Clinical Trials in Oncology · OPEN TO ACCRUAL (as of 2026)
    Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Early Stage HER2+ Breast Cancer
    NCT06876714
Completed & closed trials (1)
  • PI
    (CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
    PHASE2 · ECOG-ACRIN Cancer Research Group · CLOSED TO ACCRUAL (as of 2023)
    Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Invasive Breast Carcinoma; Prognostic Stage II Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8
    NCT04266249